LICHTGEDANKEN Cover Image: Jan-Peter Kasper (University of Jena)
English-language edition of Jena University's research magazine LICHTGEDANKEN follows scientists in their search for tailor-made drugs and targeted therapies. Light Life Liberty Inflammatory diseases, infections, cancer: in 2019 there are still many conditions for which there are either no therapies or existing treatments are insufficient. The problem is often not a lack of active substances, but rather the difficulty of getting a drug precisely and efficiently to the location of the disease. The latest edition of Friedrich Schiller University's research magazine, LICHT GEDANKEN , focuses on 'Made-to-measure-medication', presenting projects and studies in which scientists in Jena are working to create more targeted therapies. The magazine reports, for example, on pioneering research to develop nanoparticles which not only package drugs securely, but can also transport them to the desired destination and release them there. The article takes the reader into a laboratory of Jena University's Institute of Pharmacy, where nanoparticles are tested for biocompatibility in an unusual chicken's egg model. In addition to this key topic, LICHT GEDANKEN again explores a wide variety of research projects.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
